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The electrocardiogram (ECG) is a widely-used medical test, typically consisting of 12 voltage versus time traces 
collected from surface recordings over the heart. Here we hypothesize that a deep neural network can predict 
an important future clinical event (one-year all-cause mortality) from ECG voltage-time traces. We show good 
performance for predicting one-year mortality with an average AUC of 0.85 from a model cross-validated on 
1,775,926 12-lead resting ECGs, that were collected over a 34-year period in a large regional health system. 
Even within the large subset of ECGs interpreted as “normal” by a physician (n=297,548), the model performance 
to predict one-year mortality remained high (AUC=0.84), and Cox Proportional Hazard model revealed a hazard 
ratio of 6.6 (p<0.005) for the two predicted groups (dead vs alive one year after ECG) over a 30-year follow-up 
period. A blinded survey of three cardiologists suggested that the patterns captured by the model were generally 
not visually apparent to cardiologists even after being shown 240 paired examples of labeled true positives 
(dead) and true negatives (alive). In summary, deep learning can add significant prognostic information to the 
interpretation of 12-lead resting ECGs, even in cases that are interpreted as “normal” by physicians. 
 
Cardiovascular disease is prevalent, costly, 
and responsible for a large proportion of morbidity 
and mortality worldwide1. Outcomes for many forms 
of cardiovascular disease could be improved with 
better screening and risk prediction, especially with 
electrocardiograms (ECGs)2,3. The 12-lead ECG, 
typically collected at rest, is one of the most widely 
used cardiovascular diagnostic tests in the world 
with standard recommendations for assessment of a 
wide range of cardiac conditions4. Despite its 
widespread use, it is not well adopted as a 
prognostic tool3. Automated approaches to 
analyzing ECG data to provide enhanced prognostic 
capabilities may therefore have tremendous impact 
on cardiovascular disease outcomes worldwide. 
The emergence of large clinically-acquired 
ECG datasets combined with exponential growth in 
computational power and improvements in deep 
neural networks has recently enabled significant 
advancement in the automated interpretation of 
ECGs5–8. For example, in the ambulatory setting, a 
deep neural network outperformed cardiologists at 
diagnosing abnormal heart rhythms in a set of 328 
single-lead ECGs (with the model being trained on 
91,232 ECGs)9. In another study leveraging 100,000 
12-lead ECGs in the emergency room setting, a 
deep learning model was superior to traditional 
signal processing techniques for identifying acute 
findings10. Deep learning has even shown promise 
for identifying asymptomatic heart dysfunction using 
a model trained on 35,970 12-lead ECGs11,12. 
However, an automated method to predict clinically 
relevant future events, such as short-term mortality, 
directly from ECGs has not yet been developed. 
Such a predictive tool could be a valuable asset to 
aid clinicians in cardiac risk stratification with 
potentially earlier evaluation and management to 
reduce mortality risk beyond the current widely-used 
clinical risk models (for example: Framingham13, 
TIMI14, and GRACE15 scores), and the specific need 
for better mortality risk scores has been noted with 
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regard to advanced care planning and palliative 
care16–18. 
 We hypothesized that a deep neural network 
(DNN) could identify novel features recorded in 
resting 12-lead ECG voltage-time data and that 
these features could be used to directly predict an 
important future clinical event, specifically 1-year 
mortality. We leveraged nearly 1.8 million ECGs (an 
order of magnitude larger than previous studies) and 
DNN to show that this hypothesis holds true. 
Moreover, we demonstrate that a DNN has higher 
accuracy to predict 1-year mortality than a model 
developed using the traditional ECG derived 
measurements and pattern findings that are 
routinely performed clinically using ECG. Finally, we 
showed that the predictive accuracy of a DNN was 
preserved even in the large subset of ECGs 
interpreted as normal by physicians, and that three 
different cardiologists generally could not identify the 
likely subtle features the model was leveraging to 
predict survival in this subset. 
Results: 
We extracted all 12-lead ECGs from the 
electronic records of a large regional US health 
system. After excluding children (age<18), poor 
tracings, corrupted data, or patients without at least 
1 year of follow-up, there were 1,775,926 ECGs from 
397,840 patients available for the study, with 
194,845 mortality events within 1-year of the ECG 
acquisition (Supplementary Figure 1 and Table 1). 
We trained a DNN (details in methods) to aggregate 
the spatial and temporal features of the voltage-time 
signals to predict 1-year survival. We evaluated 
model performance with a 5-fold cross-validation 
scheme. The average number of ECGs across five 
folds in the training, validation and test sets were 
1,392,384 (144,214 events), 28,357 (11,662 events) 
and 355,185 (38,969 events), respectively. The loss 
function was weighted to compensate for the 
imbalance between proportion of output labels 
(alive/dead) during training. ECGs from the same 
patient were not split between train and test sets.  
First, we showed that the area under the 
receiver operating characteristic curve (AUC) for 
predicting 1-year all-cause mortality was 0.830 using 
the ECG voltage-time traces alone and improved to 
0.847 when age and sex were added as additional 
basic demographic features (transparent blue bars 
Figure 1A). During a 12-lead ECG acquisition, all 
leads are acquired for a duration of 2.5 seconds and 
three of those 12-leads (V1, II and V5) are 
additionally acquired for a duration of 10 seconds.  
Figure 1 Summary of model performance to predict one-year mortality (A) For different inputs including (i) age and sex alone 
(ii) clinically-acquired “ECG measures” (9 numerical values) and 30 diagnostic labels, (iii) ECG measures with age and sex, 
(iv) ECG voltage-time traces only and (v) ECG voltage-time traces with age and sex. We note that approximately 25% of 
the ECG traces did not have corresponding measures available in our structured database; hence, we separately report in 
(iv) and (v) model performance within all available data (transparent bars) and the 75% subset with corresponding structured 
measures available (solid bars; performance of the models was slightly lower in this subset). Note that models for (i)-(iii) 
used XGBoost and (iv)-(v) used a DNN. (B) The relative performance of the DNN models using single leads as input (sorted 
by performance). Area under the receiver operating characteristic curve is reported for the mean of five cross-validation 
folds. Error bars are standard deviation. (DNN: deep neural network). 
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Table 1 Patient demographics and summary of data distribution across predicted groups (DNN model is trained with all 
the data, including age and sex, using a likelihood threshold of 0.5). 
 All 
Train  
(fold=1) 
Validation 
(fold = 1) 
Test  
(fold = 1) 
Prediction for test fold = 1 
(model trained with *) 
Dead Alive 
ECGs (N) 1,775,926 1,390,103* 28,537 357,286 120,214 237,072 
Patients (N) 397,840 310,419 7,824 79,597 28,174 71,466 
Events (N) 194,845 143,327 11,565 39,953 32,540 7,413 
Age (year) 63.5  16.4  63.5  16.4 63.6  16.3 63.6  16.4 74.1  12.4 58.3  15.6 
Sex (Male in %) 50 50  52 50 54 48 
Patterns (30 categorical variables) in % of ECGs 
Available ECGs (N) 1,763,405 1,380,412 28,329 354,664 119,919 234,745 
Patients (N) 396,948 309,725 7,798 79,425 28,123 71,279 
Events (N) 194,307 142,991 11,501 39,815 32,462 7,353 
Normal 16.87 17.01 13.29 16.61 4.04 23.04 
Left BBB 2.82 2.80 3.51 2.84 5.34 1.56 
Right BBBB 6.20 6.20 7.10 6.13 10.22 4.04 
Incomplete LBBB 0.41 0.41 0.58 0.42 0.86 0.20 
Incomplete RBBB 3.19 3.19 3.31 3.19 2.90 3.34 
Atrial fibrillation 8.60 8.53 10.94 8.68 19.59 3.11 
Atrial flutter 1.37 1.37 1.74 1.35 2.97 0.52 
Acute MI 1.07 1.05 1.58 1.09 1.47 0.90 
LVH 7.69 7.72 7.12 7.63 9.16 6.85 
PVC 6.59 6.52 8.10 6.74 12.50 3.79 
PAC 4.89 4.89 6.21 4.81 8.01 3.17 
1st Degree block 6.30 6.27 6.22 6.42 8.11 5.56 
2nd Degree block 0.15 0.15 0.19 0.14 0.24 0.10 
Fascicular block 3.12 3.12 3.45 3.11 5.23 2.03 
Sinus Bradycardia 14.48 14.54 11.11 14.52 5.55 19.11 
Other Bradycardia 0.15 0.14 0.16 0.16 0.20 0.15 
Sinus Tachycardia 7.67 7.60 11.64 7.63 13.82 4.46 
VTach 0.10 0.10 0.19 0.10 0.29 0.01 
SVT 0.49 0.48 0.75 0.51 1.18 0.16 
Prolonged QT 5.05 4.98 6.01 5.25 8.71 3.49 
Pacemaker 4.04 4.03 4.23 4.07 7.77 2.18 
Ischemia 10.33 10.24 12.13 10.54 17.94 6.76 
Low QRS 4.52 4.44 7.06 4.60 7.30 3.21 
Intra AV block 2.13 2.12 2.82 2.14 3.99 1.20 
Prior infarct 18.20 18.11 20.75 18.32 25.18 14.82 
Nonspecific T wave 
abnormality 
13.54 13.49 14.94 13.60 16.36 12.20 
Nonspecific ST 
wave abnormality 
9.22 9.18 10.74 9.26 13.04 7.33 
Left axis deviation 8.89 8.85 10.00 8.95 13.72 6.51 
Right axis deviation 1.98 1.94 3.05 2.09 3.06 1.59 
Early repolarization 0.34 0.35 0.24 0.33 0.08 0.46 
ECG measurements (9 continuous variables) 
Available ECGs (N) 1,330,172 1,041,859 21,103 267,210 77,111 190,099 
Patients (N) 366,643 286,405 6,891 73,347 23,614 65,599 
Events (N) 125,514 91,705 8,219 25,590 19,621 5,969 
QRS duration (ms) 96.2  22.7 96.2  22.7 97.0  239 96.3  22.6 102.9  29.2 93.7  18.7 
QT (ms) 401.4  47.1 401.6  46.9 396.6  51.1 401.8  47.4 397.5  59.1 403.5  41.5 
QTC (ms) 441.7  35.9 441.5  35.7 446.7  38.3 441.9  36.1 461.8  41.4 433.8  30.2 
PR interval (ms) 163.2  38.6 163.2  38.7 161.5  39.0 163.4  39.5 164.5  51.8 163.0  33.1 
Vent rate (BPM) 75.5  18.1 75.2  18.0 79.5  20.4 75.4  18.2 84.8  20.8 71.6  15.4 
Avg RR interval (ms) 837.7  186.6 836.3  186.1 798.4  190.9 835.7  187.1 747.3  182.0 871.6  177.0 
P Axis 47.6  26.1 47.5  26.0 48.2  26.9 47.7  26.1 49.3  31.4 47.0  23.5 
R Axis 22.3  45.9 22.3  45.8 22.1  48.5 22.3  45.9 16.7  56.3 24.6  40.8 
T Axis 50.3  47.4 50.2  47.2 54.3  52.3 50.7  47.7 66.9  63.6 44.1  37.9 
N: number of samples; ms: milliseconds; BPM: beats per minute; PVC: Premature Ventricular Complexes; PAC: Premature Atrial 
Complexes; VTach: ventricular Tachycardia; SVT: Supraventricular Tachycardia; MI: Myocardial Infarction; BBB: bundle branch block; 
LVH: Left Ventricular Hypertrophy; AV: atrioventricular; Vent rate: Ventricular rate 
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The model with all 15 ECG voltage-time 
traces from the 12 standard leads together (12 leads 
acquired for 2.5 seconds plus 3 leads acquired for 
10 seconds) provided the best AUC compared to 
models derived from each single lead as input 
(Figure 1B). Models derived from the 10-second 
tracings had higher AUCs than the models derived 
from the 2.5-second tracings, demonstrating that a 
longer duration of data may provide more 
informative features to the model (Figure 1B). 
Models trained separately for males and females did 
not show improved AUC (data not shown).  
Next, we showed that the AUC from the DNN 
model derived from the voltage-time tracings alone 
was superior to a model that utilized the traditional 
measurements and patterns/diagnoses which are 
clinically reported as part of a standard 12-lead ECG 
findings. We compiled these tabular “ECG 
measures” from the clinical reports, including 9 
continuous numerical measurements (e.g. QRS 
duration) and 30 categorical ECG patterns (e.g. left 
bundle branch block) (complete list in Methods). To 
determine the predictive power of the tabular ECG 
features we trained an XGBoost (XGB) classifier19,20 
to predict 1-year mortality using these 39 “ECG 
measures”. The performance of the XGB model was 
0.772, and this improved to 0.810 with the addition 
of age and sex (Figure 1A). Note that both of these 
numbers were significantly (p<0.0001 and 
p=0.0004, respectively, with paired t-tests) below the 
AUC of the DNN model derived from the ECG traces 
either without (0.822) or with (0.831) age and sex as 
additional variables for the matched data-set (solid 
blue bars in Figure 1A). The demographics and 
distribution of ECG measures and patterns for the 
predicted groups for the DNN model with age and 
sex is summarized in Table 1, which demonstrates 
general differences between the predicted groups 
such as increased heart rate and higher prevalence 
of certain diagnoses like bundle branch blocks or 
ectopic beats in the predicted dead group. 
Subsequently, we determined the 
performance of the model in ECGs interpreted as 
“normal” by the physician compared to those with at 
least one diagnostic abnormality (which we refer to 
as “abnormal”). Note that an ECG interpreted as 
“normal” does not necessarily imply that the ECG 
was collected from a patient without cardiovascular 
disease, and we will refer to this as normal ECGs 
henceforth. On average, there were 59,510 normal 
and 293,171 abnormal ECGs in each of the 5 test 
folds. For normal ECGs, the DNN model (trained to 
predict 1-year mortality from all the ECGs) yielded 
an AUC of 0.805 and 0.841, respectively, with ECG 
traces alone and with the addition of age and sex; 
for abnormal ECGs the model yielded an AUC of 
0.817 and 0.834, respectively (Figure 1A). The same 
overall trend of the DNN utilizing the ECG traces 
alone being superior to the ECG measures held true 
across both categories of abnormal and normal 
ECGs.  
To further investigate predictive performance 
within the overall dataset and the subsets of normal 
and abnormal ECGs, Kaplan-Meier survival analysis 
was performed (Figure 2B) using follow-up data 
available in the EHR for the two groups predicted by 
the model (alive/dead in 1-year) at the chosen 
operating point (likelihood threshold = 0.5, 
sensitivity: 0.76, specificity: 0.77; see Table 2). For 
normal ECGs, the median survival times (for the 
mean survival curves of five-folds) of the two groups 
predicted alive and dead at 1-year were 26 and 8 
years, respectively, and for abnormal ECGs, 16 and 
6 years, respectively (Figure 2B). A Cox Proportional 
Hazard regression model was fit for each of the five-
folds and mean hazard ratios (with lower and upper 
bounds of 95% confidence intervals) were: 4.4 [4.0–
4.5] in all ECGs, 3.9 [3.6–4.0] in abnormal ECGs and 
6.6 [5.8–7.6] in normal ECGs (all p<0.005) 
comparing those predicted by the DNN to be alive 
versus dead at 1-year post-ECG. Thus, the hazard 
ratio was largest in the subset of normal ECGs, and 
the prediction of 1-year mortality from the DNN was 
a significant discriminator of long-term survival for up 
to 30 years after ECG.  
Next, we investigated if the features learned 
by the model are visually apparent to cardiologists 
and whether they are clinically interpretable. To do 
this, we chose 401 sets of paired normal ECGs and 
conducted a blinded survey with three cardiologists. 
Each pair consisted of a true positive (normal ECG 
correctly predicted by the model as dead at one 
year) and a true negative (normal ECG correctly 
predicted by the model as alive at one year), 
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matched for age and sex. The cardiologists 
generally had poor accuracy of 55-68% (10-36% 
above random chance) to correctly identify the 
normal ECG linked to 1-year mortality. After allowing 
each cardiologist to study a separate dataset of 240 
paired ECGs labeled to show the outcome, their 
prediction accuracy in repeating the original blinded 
survey of 401 paired ECGs remained low (50-75% 
accuracy i.e. 0-50% above random chance) (Figure 
3). 
Table 2 Summary performance statistics for different operating points of the model trained with all the data. The values 
are represented as mean  standard deviation of the five test folds. 
OP 
All data Abnormal ECGs Normal ECGs 
Sens Spec PPV NPV Sens Spec PPV NPV Sens Spec PPV NPV 
0.25 
0.88 
 
0.01 
0.64 
 
0.02 
0.23 
 
0.01 
0.98 
 
0.001 
0.90 
  
0.01 
0.58 
  
0.02 
0.24 
 
0.01 
0.98 
 
0.001 
0.62 
  
0.03 
0.87 
 
0.01 
0.14 
 
0.01 
0.99 
 
0.001 
0.5 
0.76 
 
0.02 
0.77 
 
0.02 
0.29 
 
0.01 
0.96 
 
0.002 
0.79 
 
0.02 
0.73 
 
0.02 
0.30 
 
0.01 
0.96 
 
0.002 
0.42 
 
0.03 
0.95 
 
0.01 
0.21 
 
0.01 
0.98 
 
0.001 
0.75 
0.54 
 
0.04 
0.90 
 
0.01 
0.39 
 
0.02 
0.94 
 
0.003 
0.56 
 
0.04 
0.88 
  
0.01 
0.39 
 
0.02 
0.93 
 
0.003 
0.18 
 
0.04 
0.99 
  
0.004 
0.32 
 
0.02 
0.97 
 
0.001 
OP: operating point; Sens: Sensitivity; Spec: Specificity; 
PPV: positive predictive value; NPV: negative predictive value 
 
 
Figure 2 Receiver operating characteristic (ROC) curves of the trained model for the chosen operating points (threshold on 
likelihood = 0.5) and corresponding Kaplan-Meier (KM) survival curves. (A) ROC curves (mean of five test folds with shaded 
95% confidence region) with operating points for the folds marked for all the data (black), the normal ECG subset (blue) 
and the abnormal ECG subset (red). (B) The mean KM curves for predicted alive and dead groups in the normal and 
abnormal ECG subsets of the five folds. The shaded areas are lower and upper bounds of 95% confidence intervals of the 
five folds. The table shows the at risk population for the given time intervals for all the five test folds combined. 
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We chose to predict 1-year, all-cause 
mortality as an initial target endpoint given its ready 
availability with high accuracy and less risk of bias 
related to clinical input, documentation or 
opinion.  Given the good predictive capability we 
identified using an “all-cause” outcome, we expect 
that similar models built using voltage-time data will 
be equally or more accurate for predicting more 
specific cardiovascular outcomes in future work. 
Though these data had inherent heterogeneity 
(which is important for building a generalizable 
model) since they were collected within a large 
regional healthcare system with 13 hospitals and 
hundreds of clinics over almost 4 decades, 
additional independent datasets will be required to 
assess more widespread generalizability. 
Unfortunately, procuring and curating a large 
external dataset with similar longitudinal outcomes 
annotation is currently a prohibitive challenge for 
validation.  
 
Discussion: 
In summary, we leveraged a large set of 
nearly 1.8 million ECGs collected from ~400 
thousand patients over a period of 34 years to 
demonstrate the potential for DNNs to automatically 
predict a highly clinically relevant endpoint (1-year 
mortality) directly from 12-lead ECG voltage-time 
data. This potential is evident through several critical 
findings. First, the DNN model using voltage-time 
traces outperformed another machine learning 
model that utilized an extensive collection of 39 
clinically-derived ECG features (including both 
numerical measurements and diagnostic patterns), 
suggesting that the model is able to identify novel 
patterns of significant prognostic importance from 
voltage-time traces. Second, the DNN model not 
only can predict 1-year mortality with AUC of 0.847, 
but also shows considerable prognostic value in 
longer time survival characteristics among the 
predicted groups with median survival being over 3-
times longer in patients with ECGs predicted to be 
alive versus dead. Finally, despite the canonical 
wisdom of the high negative predictive value of 
ECGs21,22, we found that prediction accuracy 
remained high even in the large subset of ECGs 
clinically interpreted as “normal” by a cardiologist. 
This suggests that features interpreted by the model 
were not generally apparent to cardiologists upon re-
evaluation, even after being shown 240 paired 
examples of labeled true positives and negatives, 
further underscoring their novelty. Machine learning 
therefore has potential to add significant prognostic 
information to the clinical interpretation of one of the 
most widely-used medical tests and possibly risk 
stratify patients who may benefit from preventive 
interventions.  
 
 
  
Figure 3 Accuracy for the three 
cardiologists to correctly identify the 
true positive ECG (dead within a 
year) when presented with two 
‘normal’ ECGs corresponding to a 
paired set of a true positive and true 
negative (n=401) (black bars). 
Accuracy is also shown (grey bars) 
for the same survey after being 
shown an independent set (n=240) 
with outcomes labeled. All ECG 
pairs presented were matched for 
age and sex. 
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Methods: 
 
ECG and patient data: 
The Institutional Review Board approved this 
study with a waiver of consent. We extracted 2.6 
million standard 12-lead ECG traces from our 
institutional clinical MUSE (GE Healthcare, WI) 
database, acquired between 1984 and 2018. We 
retained only the resting 12-lead ECGs with voltage-
time traces of 2.5 seconds for 12-leads and 10 
seconds for 3 leads (V1, II, V5) that did not have 
significant artifacts and were associated with at-least 
a year of follow-up or death within a year. This 
amounted to 1.8 million ECGs where 51% of them 
were stored at 500 Hz and the remaining were 
stored at 250 Hz. All data therefore was resampled 
to 500 Hz by linear interpolation. Characteristics of 
the final patient population are shown (Table 1). We 
further cross-referenced the patient identifiers with 
the most recent clinical encounters and a regularly-
updated death index registry at our institution to 
assign patient status (dead/alive). These data were 
divided into five folds with five percent of the training 
data set aside as a validation set. The data were split 
such that the same patient was not in both train and 
test sets for cross-validation. The outcomes were 
approximately balanced in the validation set. 
Additionally, the findings within the final ECG 
clinical reports were parsed to identify 30 diagnostic 
pattern classes and 9 continuous ECG 
measurements (all detailed below). Each ECG was 
defined to be “abnormal” if the pattern label was 
flagged for at least one diagnostic abnormality. The 
9 ECG measurements included QRS duration, QT, 
QTC, PR interval, ventricular rate, Average RR 
interval and P, Q and T-wave axes. Patterns 
included normal, left bundle branch block, 
incomplete left bundle branch block, right bundle 
branch block, incomplete right bundle branch block, 
atrial fibrillation, atrial flutter, acute myocardial 
infarction, left ventricular hypertrophy, premature 
ventricular contractions, premature atrial 
contractions, first degree block, second degree 
block, fascicular block, sinus bradycardia, other 
bradycardia, sinus tachycardia, ventricular 
tachycardia, supraventricular tachycardia, 
prolonged QT, pacemaker, ischemia, low QRS 
voltage, intra-atrioventricular block, prior infarct, 
nonspecific t-wave abnormality, nonspecific ST 
wave abnormality, left axis deviation, right axis 
deviation and early repolarization. The tabular ECG 
features were only available within 75% of all the 
available ECGs.  
The survival time and patient age were 
calculated with reference to the date of ECG 
acquisition and only patients above 18 years of age 
at the time of ECG were included in this study. Sex 
was also extracted from the EHR data. Note that 
death data are highly accurate in our EHR due to 
regular checks against death index databases, 
however, survival was not assumed without a known 
living encounter. 
 
Model development and evaluation: 
We designed a convolutional neural network 
(model architecture illustrated in Figure 4) with 5 
branches with the input of 3 leads as channels that 
are concurrent in time, i.e., (Branch 1: [I, II, III]; 2: 
[aVR, aVL, aVF]; 3: [V1, V2, V3]; 4: [V4, V5, V6] and 
5: [V1-long, II-long, V5-long]). Note that each branch 
represents the 3 leads that were acquired at the 
same time (during the same heartbeats), for a 
duration 2.5 seconds. In a typical 12-lead ECG, 4 of 
these groups of 3 leads are consecutively acquired 
over a duration of 10 seconds. Concurrently, the 
“long leads” are recorded over the entire 10-second 
duration. Thus, the architecture was designed to 
account for these details since arrhythmias, in 
particular, cause the traces to change morphology 
throughout the standard clinical acquisition.  
A convolutional block consisted of a 1-
dimensional convolution layer followed by batch 
normalization and rectified linear units (ReLU)23 
activations. The first four branches and last branch 
consisted of 4 and 6 convolutional blocks, 
respectively, followed by a Global Average Pooling 
(GAP)24 layer. The outputs of all the branches were 
then concatenated and connected to a series of 6 
dense layers of 256 (with dropout), 128 (with 
dropout), 64, 32, 8 and 1 unit(s) with a sigmoid 
function as the final layer. We used Adam25 
optimizer with a learning rate of 1e-5 and batch size 
of 2048 and computed each model branch in parallel 
on a separate GPU for faster computation. 
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Replacing the GAP layer with long short-term 
memory26 gave similar performance for significantly 
longer run times; hence, the final model used GAP 
layers.  
We evaluated loss (binary cross-entropy) on 
the validation set for each epoch. The training was 
terminated if the validation loss did not decrease for 
10 epochs (early-stopping criteria), and the 
maximum number of epochs was set to 500. The 
model was implemented using Keras (version: 2.1.6-
tf) with a TensorFlow backend (version: 1.9.0) in 
python (version: 3.5.2) and default training 
parameters were used except where specified. For 
single leads as input, a single branch of the 
Figure 4 Model Architecture used in the study. 
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abovementioned model was used. When 
demographic variables (age and sex) were added to 
the model, a 64 hidden unit layer following the input 
layer was concatenated with other branches. All 
training was performed on an NVIDIA DGX1 
platform with eight V100 GPUs and 32 GB of RAM 
per GPU. We independently fit each fold on 5 GPUs 
and each epoch took ~10 mins. We evaluated the 
performance of the model with 5-fold cross-
validation to predict 1-year mortality. 
To compare the prognostic efficacy of the 
ECG voltage-time traces with corresponding 
clinically reported “ECG measures”, we cross-
validated an XGB classifier with the same folds 
identified above. In order to fairly compare the 
performance of XGB models to the DNN that 
ingested the voltage-time data, in a paired fashion, 
we re-trained the DNNs using only the studies 
(approximately 75% of the total) which had ECG 
measures available. The XGB classifier performed 
better than a random forest classifier. 
 
Survival analysis:  
We performed Kaplan-Meier survival 
analysis27 with the available follow-up data stratified 
by the DNN model prediction, using a likelihood 
threshold of 0.5 as the operating point. The data 
were censored based on the most recent encounter. 
We fit a Cox Proportional Hazard model28 regressing 
mortality on the DNN model-predicted classification 
of alive and dead in the subset of normal ECGs and 
the subset of abnormal ECGs. The mean values and 
lower and upper bounds of the 95% confidence 
intervals across the five folds were reported. The 
lifelines package (version: 0.18.6) in python was 
used for survival analysis. 
 
Survey:  
In an effort to identify the differential clinical 
features between true positives and true negatives 
in ECGs interpreted as normal by a physician, we 
designed a series of surveys for three independent 
cardiologists. Pairs of ECGs, including one true 
positive (correctly predicted by the model to 
associate with death at 1 year) and one true negative 
(correctly predicted by the model to associate with 
survival at 1 year), matched for age and sex, were 
presented to each cardiologist, blinded to the model 
outcome. The cardiologists were asked to assess 
the presented ECGs for the patient at risk of death 
in a year and were told that one of the two presented 
ECGs was a true positive and the other a true 
negative. Sample size required for the 1-sample 
binomial test for true proportion and null hypothesis 
proportion equal to 0.6 and 0.5, respectively, with 
power of 0.8 and type I error rate of 1% was 
calculated to be 280. With model predictions of 
likelihood threshold greater than 0.75, 401 true 
positive ECGs were identified and matched with true 
negative ECGs with prediction likelihood threshold 
less than 0.25. The final ECG clinical interpretations 
(including the 9 computed ECG measurements and 
findings by the original interpreting cardiologist) 
were also presented to the cardiologists along with 
sex and age. After this was completed, the 
cardiologists were then shown an independent set of 
240 pairs of ECGs in the same setup as above with 
the outcomes shown in order to help them identify 
potential differential clinical features. Without being 
told the accuracy or results of the initial survey, each 
cardiologist then reviewed the original blinded 
survey again after being shown the survey with 
marked outcomes.  
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Supplementary Figure 1 Summary of data used in the study. 
